최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of nutrition and health, v.50 no.3, 2017년, pp.225 - 235
안영숙 (이화여자대학교 식품영양학과) , (이화여자대학교 식품영양학과) , 오은경 (이화여자대학교 식품영양학과) , 권오란 (이화여자대학교 식품영양학과)
Purpose: This study aimed to investigate the potential of freeze-dried persimmon powder (Diospyros kaki Thumb.) to protect against dyslipidemia induced by a high-fat/cholesterol diet (HFD) in a rat model. Methods: Fifty Wistar rats were randomly divided into five groups: normal control (NC), high-fa...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
이상지질혈증이란 무엇인가? | 현대사회는 서구화된 식생활 습관과 운동 부족으로 이상지질혈증의 위험이 증가되며, 이로 인한 동맥경화증, 뇌졸중, 심근경색증 등 심뇌혈관질환 사망률도 증가하여 사회적인 문제가 되고 있다. 이상지질혈증이란 혈액의 총콜레스테롤 (total cholesterol, TC) 240 mg/dL 이상, 중성지방 (triglycerol, TG) 200 mg/dL 이상, 그리고 저밀도지단백 콜레스테롤 (low-density lipoprotein cholesterol, LDL-C) 160 mg/dL 이상 이거나, 고밀도지단백 콜레스테롤(high-density lipoprotein cholesterol, HDL-C)이 40 mg/dL 이하인 상태를 말한다.1 따라서 고지혈증, 고콜레스테롤혈증, 고중성지방혈증 등의 용어들이 유사한 의미로 통용되고 있다. | |
국내 이상지질혈증 진료 환자 현황은? | 1 따라서 고지혈증, 고콜레스테롤혈증, 고중성지방혈증 등의 용어들이 유사한 의미로 통용되고 있다. 국민건강영양조사에 따르면, 우리나라 30세 이상성인 중 이상지질혈증 진료 환자수는 매년 꾸준히 증가하고 있으며, 2015년 고콜레스테롤혈증 유병률은 17.9%, 그리고 고중성지방혈증 유병률은 16.8%로 이상지질혈증의 개선이 중요시되고 있다.2 이에 따라 이상지질혈증을 치료하기 위해 다양한 약물이 개발되고 있다. | |
이상지질혈증과 유사한 의미로 쓰이는 다른 용어는? | 이상지질혈증이란 혈액의 총콜레스테롤 (total cholesterol, TC) 240 mg/dL 이상, 중성지방 (triglycerol, TG) 200 mg/dL 이상, 그리고 저밀도지단백 콜레스테롤 (low-density lipoprotein cholesterol, LDL-C) 160 mg/dL 이상 이거나, 고밀도지단백 콜레스테롤(high-density lipoprotein cholesterol, HDL-C)이 40 mg/dL 이하인 상태를 말한다.1 따라서 고지혈증, 고콜레스테롤혈증, 고중성지방혈증 등의 용어들이 유사한 의미로 통용되고 있다. 국민건강영양조사에 따르면, 우리나라 30세 이상성인 중 이상지질혈증 진료 환자수는 매년 꾸준히 증가하고 있으며, 2015년 고콜레스테롤혈증 유병률은 17. |
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25): 3143-3421.
Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Sejong: Korea Centers for Disease Control and Prevention; 2016.
Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med 2001; 5(4): 378-387.
Al-Mohaissen MA, Ignaszewski MJ, Frohlich J, Ignaszewski AP. Statin-associated muscle adverse events: update for clinicians. Sultan Qaboos Univ Med J 2016; 16(4): e406-e415.
Duell PB, Connor WE. Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins. Circulation 2008; 118 (Suppl 18): S470.
Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007; 25(10): 1135-1151.
Yokozawa T, Park CH, Noh JS, Roh SS. Role of oligomeric proanthocyanidins derived from an extract of persimmon fruits in the oxidative stress-related aging process. Molecules 2014; 19(5): 6707-6726.
Jang IC, Jo EK, Bae MS, Lee HJ, Jeon GI, Park E, Yuk HG, Ahn GH, Lee SH. Antioxidant and antigenotoxic activities of different parts of persimmon (Diospyros kaki cv. Fuyu) fruit. J Med Plant Res 2010; 4(2): 155-160.
Lee YA, Cho EJ, Tanaka T, Yokozawa T. Inhibitory activities of proanthocyanidins from persimmon against oxidative stress and digestive enzymes related to diabetes. J Nutr Sci Vitaminol (Tokyo) 2007; 53(3): 287-292.
Lee JS, Lee MK, Ha TY, Bok SH, Park HM, Jeong KS, Woo MN, Do GM, Yeo JY, Choi MS. Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem Toxicol 2006; 44(11): 1875-1883.
Matsumoto K, Yokoyama S, Gato N. Hypolipidemic effect of young persimmon fruit in C57BL/6.KOR-ApoEshl mice. Biosci Biotechnol Biochem 2008; 72(10): 2651-2659.
Gorinstein S, Bartnikowska E, Kulasek G, Zemser M, Trakhtenberg S. Dietary persimmon improves lipid metabolism in rats fed diets containing cholesterol. J Nutr 1998; 128(11): 2023-2027.
Matsumoto K, Yokoyama S, Gato N. Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice. Phytother Res 2010; 24(2): 205-210.
Gorinstein S, Leontowicz H, Leontowicz M, Jesion I, Namiesnik J, Drzewiecki J, Park YS, Ham KS, Giordani E, Trakhtenberg S. Influence of two cultivars of persimmon on atherosclerosis indices in rats fed cholesterol-containing diets: Investigation in vitro and in vivo. Nutrition 2011; 27(7-8): 838-846.
Zou B, Ge ZZ, Zhang Y, Du J, Xu Z, Li CM. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing $NF-{\kappa}B$ activation and inflammatory responses in high-fat diet rats. Food Funct 2014; 5(7): 1536-1546.
Zou B, Li C, Chen J, Dong X, Zhang Y, Du J. High molecular weight persimmon tannin is a potent hypolipidemic in high-cholesterol diet fed rats. Food Res Int 2012; 48(2): 970-977.
Matsumoto K, Kadowaki A, Ozaki N, Takenaka M, Ono H, Yokoyama S, Gato N. Bile acid-binding ability of kaki-tannin from young fruits of persimmon (Diospyros kaki) in vitro and in vivo. Phytother Res 2011; 25(4): 624-628.
Matsumoto K, Yokoyama S. Induction of uncoupling protein-1 and -3 in brown adipose tissue by kaki-tannin in type 2 diabetic NSY/Hos mice. Food Chem Toxicol 2012; 50(2): 184-190.
Gorinstein S, Kulasek GW, Bartnikowska E, Leontowicz M, Zemser M, Morawiec M, Trakhtenberg S. The influence of persimmon peel and persimmon pulp on the lipid metabolism and antioxidant activity of rats fed cholesterol. J Nutr Biochem 1998; 9(4): 223-227.
Gorinstein S, Kulasek GW, Bartnikowska E, Leontowicz M, Zemser M, Morawiec M, Trakhtenberg S. The effects of diets, supplemented with either whole persimmon or phenol-free persimmon, on rats fed cholesterol. Food Chem 2000; 70(3): 303-308.
Park YS, Leontowicz H, Leontowicz M, Namiesnik J, Jesion I, Gorinstein S. Nutraceutical value of persimmon (Diospyros kaki Thunb.) and its influence on some indices of atherosclerosis in an experiment on rats fed cholesterol-containing diet. Adv Hortic Sci 2008; 22(4): 250-254.
Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226(1): 497-509.
Seong JH, Han JP. The qualitative differences of persimmon tannin and the natural removal of astringency. Korean J Postharvest Sci Technol 1999; 6(1): 66-70.
Beninger CW, Hosfield GL. Antioxidant activity of extracts, condensed tannin fractions, and pure flavonoids from Phaseolus vulgaris L. seed coat color genotypes. J Agric Food Chem 2003; 51(27): 7879-7883.
Serrano J, Puupponen-Pimia R, Dauer A, Aura AM, Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009; 53 Suppl 2: S310-S329.
Gu HF, Li CM, Xu Y, Hu W, Chen M, Wan Q. Structural features and antioxidant activity of tannin from persimmon pulp. Food Res Int 2008; 41(2): 208-217.
Gato N, Kadowaki A, Hashimoto N, Yokoyama S, Matsumoto K. Persimmon fruit tannin-rich fiber reduces cholesterol levels in humans. Ann Nutr Metab 2013; 62(1): 1-6.
Karaman S, Toker OS, Yuksel F, Cam M, Kayacier A, Dogan M. Physicochemical, bioactive, and sensory properties of persimmonbased ice cream: technique for order preference by similarity to ideal solution to determine optimum concentration. J Dairy Sci 2014; 97(1): 97-110.
Lee SH. Diagnosis and treatment of dyslipidemia. Korean J Med 2008; 74(4): 358-362.
Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 1998; 101(11): 2331-2339.
Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev 2006; 86(2): 465-514.
Amemiya-Kudo M, Shimano H, Hasty AH, Yahagi N, Yoshikawa T, Matsuzaka T, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Sato R, Kimura S, Ishibashi S, Yamada N. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 2002; 43(8): 1220-1235.
Willnow TE, Sheng Z, Ishibashi S, Herz J. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 1994; 264(5164): 1471-1474.
Osono Y, Woollett LA, Herz J, Dietschy JM. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 1995; 95(3): 1124-1132.
Temel RE, Brown JM. A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion. Trends Pharmacol Sci 2015; 36(7): 440-451.
Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 2000; 275(19): 14700-14707.
Chiang JY, Kimmel R, Weinberger C, Stroup D. Farnesoid X receptor responds to bile acids and represses cholesterol $7{\alpha}$ -hydroxylase gene (CYP7A1) transcription. J Biol Chem 2000; 275(15): 10918-10924.
Matsumoto K, Takekawa K. Comparison of the effects of three persimmon cultivars on lipid and glucose metabolism in high-fat diet-fed mice. J Nutr Sci Vitaminol (Tokyo) 2014; 60(5): 340-347.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.